News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
22hon MSN
U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...
The CDC, a $9.2 billion-a-year agency tasked with reviewing life-saving vaccines, monitoring diseases and watching for ...
Dr. Marty Makary, the Johns Hopkins surgeon and professor whom President Donald Trump tapped to lead the U.S. Food and Drug ...
4don MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback